LexDanaLexDanabeta
Inventor

Kura Rathnakar Reddy

Inventor
Hyderabad, IN

Overview

59→
Patents
2006–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds9%
C07BGeneral methods of organic chemistry6%
C07JSteroids4%
B01FMixing, e.g. dissolving, emulsifying or dispersing1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07HSugars1%
C12MApparatus for enzymology or microbiology1%
PatentTitleYear
10,822,314Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound202010,815,204Process for the preparation of diphenylpyrazine derivatives202010,562,867Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound202010,533,035C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors202010,464,931Process for the preparation of Quinolin-2(1H)-one derivatives201910,336,706Crystalline form of Eltrombopag free acid201910,329,281Polymorphs and process for the preparation of quinazolinyl derivatives201910,214,497Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound201910,206,874Rufinamide solid dispersion201910,023,526Process for the preparation of lomitapide20189,783,542'Process for pralatrexate'20179,637,516'Betulinic acid proline derivatives as HIV inhibitors'20179,624,207'Polymorphs of azilsartan medoxomil'20179,624,236'Amorphous darunavir'20179,624,172'Polymorphs of lomitapide and its salts'20179,518,020'Process for Regorafenib'20169,381,199'Linagliptin solid dispersion'20169,175,005'Crystalline hydrochloride salt of darunavir'20159,156,789'Process for sorafenib tosylate polymorph III'20159,139,535'Process for rilpivirine using novel intermediate'20159,115,118'Process for the resolution of omeprazole'20159,067,966'Lupeol-type triterpene derivatives as antivirals'20158,921,606'Process for cinacalcet hydrochloride'20148,912,333'Polymorphs of pitavastatin calcium'20148,802,727'Pharmaceutically acceptable salts of betulinic acid derivatives'20148,748,619'Process for the resolution of omeprazole'20148,598,341'Process for etravirine intermediate and polymorphs of etravirine'20138,552,036'Polymorph of atazanavir sulfate'20138,536,151'Process for preparing lamivudine polymorph form'20138,492,577'Process for preparation of valsartan intermediate'20138,471,012'Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B'20138,466,279'Polymorphs of efavirenz'20138,445,506'Polymorphs of lopinavir'20138,420,822'Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles'20138,389,531'Process for erlotinib hydrochloride'20138,383,811'Process for preparing efavirenz polymorph'20138,361,507'Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan'20138,354,541'Optical purification of esomeprazole'20138,242,267'Polymorphs of efavirenz'20128,106,210'Polymorphs of esomeprazole salts'20127,947,840'Process for preparation of enantiomerically pure esomeprazole'20117,858,812'Process for isolation of desired isomers of nebivolol intermediates'20107,834,027'Gemifloxacin process and polymorphs'20107,772,401'Process for the preparation of lercanidipine'20107,772,399'Process for amorphous form of donepezil hydrochloride'20107,750,153'Process for the preparation of didanosine using novel intermediates'20107,737,273'Process for acyclic phosphonate nucleotide analogs'20107,732,632'Process for obtaining pure oseltamivir'20107,705,142'Process for the preparation of cefixime'20107,687,658'Process for oseltamivir phosphate'20107,687,653'Process for the preparation of lercanidipine'20107,638,634'Amorphous esomeprazole hydrate'20097,629,482'Process for preparation of cefprozil intermediate'20097,563,812'Amorphous esomeprazole hydrate'20097,365,206'Stereoselective synthesis of benzimidazole sulfoxides'20087,361,770'Process for preparation of valsartan'20087,205,415'Process for the preparation of simvastatin'20077,176,319'Process for substituted sulfoxides'20077,067,675'Process for ezetimibe intermediate'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2013Patents assigned to HETERO DRUGS LTD (25)· patent assignee history
2006–2020Based in Hyderabad, IN· patent location history
2009–2015Based in Andhrapradesh, IN· patent location history
2012–2017Patents assigned to PARTHASARADHI REDDY BANDI (22)· patent assignee history
2012–2017Patents assigned to RATHNAKAR REDDY KURA (22)· patent assignee history
2012–2017Patents assigned to MURALIDHARA REDDY DASARI (20)· patent assignee history
2013–2019Patents assigned to HETERO RESEARCH FOUNDATION (25)· patent assignee history
2013–2017Based in Andhra Pradesh, IN· patent location history
2017Based in Hyderbad, IN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HETERO DRUGS LTD252006–2013
HETERO RESEARCH FOUNDATION252013–2019
PARTHASARADHI REDDY BANDI222012–2017
RATHNAKAR REDDY KURAself222012–2017
MURALIDHARA REDDY DASARI202012–2017
Locations
LocationPatentsSpan
Hyderabad, IN502006–2020
Andhra Pradesh, IN42013–2017
Andhrapradesh, IN42009–2015
Hyderbad, IN12017